Predicting 28-Day Survival in OHCA Patients

CompletedOBSERVATIONAL
Enrollment

327

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

June 1, 2024

Conditions
Out of Hospital Cardiac ArrestCardiac Arrest (CA)
Interventions
OTHER

Demographics

The demographic profile of each patient was documented, including age and sex, to examine potential associations with survival and neurological outcomes.

OTHER

Comorbidities

Data on pre-existing chronic conditions were recorded, such as hypertension, diabetes mellitus, coronary artery disease, chronic kidney disease, and malignancy, in order to assess their potential impact on prognosis following OHCA.

OTHER

Prehospital Variables

Several prehospital factors were evaluated, including whether the cardiac arrest was witnessed, whether bystander CPR was performed, the time from collapse to the initiation of CPR, and the time from collapse to EMS arrival. Additionally, the durations of no-flow (i.e., time without any CPR) and low-flow (i.e., time with CPR but without ROSC) were noted. The initial cardiac rhythm was categorized as ventricular fibrillation or pulseless ventricular tachycardia (VF/pVT), asystole, or pulseless electrical activity (PEA). Airway management methods used in the field were documented and classified as bag-valve-mask (BVM), supraglottic airway devices (SGAs), or endotracheal intubation (ETI). Other recorded interventions included prehospital defibrillation, administration of epinephrine (including total dosage), and use of mechanical chest compression devices. Whether ROSC was achieved prior to arrival at the emergency department was also noted.

DIAGNOSTIC_TEST

Hematological Parameters

These included white blood cell count (WBC), hemoglobin level, platelet count, mean platelet volume (MPV), and differential counts such as neutrophils, monocytes, and eosinophils.

DIAGNOSTIC_TEST

Biochemical Parameters

Measurements included creatinine, urea, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), sodium, potassium, chloride, calcium, and troponin-I levels.

DIAGNOSTIC_TEST

Arterial Blood Gas Parameters

The primary clinical outcomes recorded for each patient included return of spontaneous circulation (ROSC), 28-day survival or mortality, and neurological status, which was later assessed using the Cerebral Performance Category (CPC) scale.

Trial Locations (1)

34265

Haseki Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Haseki Training and Research Hospital

OTHER

NCT07023159 - Predicting 28-Day Survival in OHCA Patients | Biotech Hunter | Biotech Hunter